Understanding the physiology behind SGLT2 inhibitors

Understanding the physiology behind SGLT2 inhibitors

Ellen Behrend, VMD, PhD, MS, DACVIM, describes a sodium-glucose cotransporter-2 inhibitor in a dvm360 interview.

SGLT2 inhibitors in heart failure - Australian Pharmacist

Heart failure remains a significant health burden, but modern medicines, particularly SGLT2is, can offer significant benefits.

SGLT2 Inhibitors Show Renal Benefits in HF and CKD as Prescribers Target Uptake Gaps

Abstracts featured at the National Kidney Foundation Spring Clinical Meeting highlighted the renoprotective benefits of SGLT2 inhibitors in heart failure and diabetic kidney disease while emphasizing the need for strategies to increase their uptake in primary care.